Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trials
3 of 3 indexed Chemotherapy Induced Peripheral Neuropathy (CIPN) trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Chemotherapy Induced Peripheral Neuropathy (CIPN): 3 US clinical trials tracked, 3 recruiting.
Chemotherapy Induced Peripheral Neuropathy (CIPN) is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Luminate Medical, running 1 of these trials.
Enrollment posture brief
Registry condition chemotherapy-induced-peripheral-neuropathy-cipn
OPEN 3 | RECR 100% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Chemotherapy Induced Peripheral Neuropathy (CIPN) lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chemotherapy Induced Peripheral Neuropathy (CIPN) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chemotherapy Induced Peripheral Neuropathy (CIPN) is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The Lilac Device Trial
Luminate Medical
NCT07142304
Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
University of Florida
NCT07009717
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Dana-Farber Cancer Institute
NCT06807294
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Chemotherapy Induced Peripheral Neuropathy (CIPN) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chemotherapy Induced Peripheral Neuropathy (CIPN) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chemotherapy Induced Peripheral Neuropathy (CIPN) page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Chemotherapy Induced Peripheral Neuropathy (CIPN) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Luminate Medical sponsors the most Chemotherapy Induced Peripheral Neuropathy (CIPN) trials on record, review their full trial history before evaluating a specific study. See Luminate Medical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chemotherapy Induced Peripheral Neuropathy (CIPN) condition card totals 3 registered trials; most-linked intervention The Lilac Device; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.